Autopsy report · NCT00577109

A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Study was cancelled before patient enrollment”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2
Sponsor: Hoffmann-La Roche
Sponsor type: Industry
Conditions: Colorectal Cancer
Interventions: bevacizumab [Avastin]; Irinotecan; Leucovorin; 5 FU; Cetuximab
Participants: 0
Sites: 3
Countries: Brazil

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.